APO IMA 100 (Imatinib mesylate 100 mg)
Pill imprint APO IMA 100 has been identified as Imatinib mesylate 100 mg.
Imatinib is used in the treatment of chronic myelogenous leukemia; gastrointestinal stromal tumor; acute lymphoblastic leukemia; chronic eosinophilic leukemia; myeloproliferative disorders (and more), and belongs to the drug class BCR-ABL tyrosine kinase inhibitors. There is positive evidence of human fetal risk during pregnancy. Imatinib 100 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- APO IMA 100
- Strength:
- 100 mg
- Color:
- Orange
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- BCR-ABL tyrosine kinase inhibitors
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Apotex Corp.
More about imatinib
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 34 Reviews – Add your own review/rating
- Drug class: BCR-ABL tyrosine kinase inhibitors
Consumer resources
Other brands: Gleevec
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
